BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1594247)

  • 1. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
    Srivatsan ES; Murali V; Seeger RC
    Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations involving chromosome 1p in children with neuroblastoma.
    Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
    Suzuki T; Yokota J; Mugishima H; Okabe I; Ookuni M; Sugimura T; Terada M
    Cancer Res; 1989 Mar; 49(5):1095-8. PubMed ID: 2563671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M; Berthold F; Edler L; Schwab M; Amler LC
    Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
    Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
    Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R
    Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung.
    Yokoyama S; Yamakawa K; Tsuchiya E; Murata M; Sakiyama S; Nakamura Y
    Cancer Res; 1992 Feb; 52(4):873-7. PubMed ID: 1346586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
    Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.
    Caron H
    Med Pediatr Oncol; 1995 Apr; 24(4):215-21. PubMed ID: 7700165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
    Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
    Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.
    Takeda O; Homma C; Maseki N; Sakurai M; Kanda N; Schwab M; Nakamura Y; Kaneko Y
    Genes Chromosomes Cancer; 1994 May; 10(1):30-9. PubMed ID: 7519871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.